Felix Bock
Overview
Explore the profile of Felix Bock including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
90
Citations
1764
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Haake L, El Menuawy A, Rennau H, Marthe F, Hahnel U, Bock F, et al.
Int J Mol Sci
. 2025 Jan;
26(2.
PMID: 39859336
To enhance the treatment of tumors that are resistant to radio- and chemotherapy while minimizing the side effects of radiochemotherapy, researchers are continuously seeking new active compounds for use in...
2.
Burtin F, Elias L, Hinz S, Forster M, Hildebrandt G, Frerker B, et al.
J Cancer Res Clin Oncol
. 2024 Sep;
150(9):428.
PMID: 39307893
Background: Liquid biopsy is a minimally invasive procedure investigating tumor mutations. Methods: In our retrospective study, we investigated whether molecular therapy monitoring of patients receiving neoadjuvant radio(chemo)therapy on a daily...
3.
Dietrich-Ntoukas T, Bock F, Onderka J, Hos D, Bachmann B, Zahn G, et al.
J Clin Med
. 2024 Aug;
13(15).
PMID: 39124685
Corneal inflammatory hem- and lymphangiogenesis significantly increase the risk for immune rejection after subsequent allogeneic corneal transplantation. The purpose of this study was to analyze the impact of temporary selective...
4.
Hou Y, Zhang W, Le V, Deng S, Hadrian K, Mestanoglu M, et al.
Acta Ophthalmol
. 2024 Apr;
102(7):e1002-e1010.
PMID: 38687167
Purpose: To compare safety and efficacy of isolated and combined UV-light corneal crosslinking (CXL) and fine-needle diathermy (FND) to regress pathological corneal vessels in vivo. Methods: Mice with inflamed and...
5.
Bock F, Frerker B, Schubert L, Rennau H, Kurth J, Krause B, et al.
Nuklearmedizin
. 2024 Apr;
63(3):199-206.
PMID: 38580313
Aim: This study aimed to assess the impact of Ga-PSMA PET/CT on radiation treatment (RT) planning in prostate cancer patients with salvage (sRT) or definitive (dRT) radiotherapy. Methods: 38 patients...
6.
Peil J, Vossen C, Bock F, Clahsen T, Schiller P, Heindl L, et al.
J Immunol
. 2023 Dec;
212(3):487-499.
PMID: 38099710
Angiogenesis and immune protection are essential at the onset of tumorigenesis. Angiogenesis serves to nourish the tumor, and prevention of immune defenses, for example, by dendritic cells (DCs), allows tumor...
7.
Hamdorf M, Imhof T, Bailey-Elkin B, Betz J, Theobald S, Simonis A, et al.
J Mol Cell Biol
. 2023 Oct;
15(10).
PMID: 37891014
The novel coronavirus pandemic, first reported in December 2019, was caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). SARS-CoV-2 infection leads to a strong immune response and activation...
8.
Frerker B, Bock F, Cappel M, Kriesen S, Klautke G, Hildebrandt G, et al.
Int J Mol Sci
. 2023 Jun;
24(12).
PMID: 37373535
To date, oxaliplatin and irinotecan are used in combination with 5-flourouracil (5-FU) for metastatic colorectal cancer. In this study it was tested whether oxaliplatin and irinotecan and their combinations with...
9.
Howaldt A, Zhang W, Deng S, Becker M, Hou Y, Clahsen T, et al.
Acta Ophthalmol
. 2023 Jun;
102(1):e134-e137.
PMID: 37259477
No abstract available.
10.
Weiss M, Domschikowski J, Krug D, Sonnhoff M, Nitsche M, Hoffmann W, et al.
Clin Transl Radiat Oncol
. 2023 May;
41:100633.
PMID: 37206410
Purpose: Palliative radiotherapy for patients with head and neck cancer can be used to alleviate symptoms. Only a few studies have investigated its impact on patient-reported outcomes (PRO). Therefore, we...